What we do
Our approach
Pipeline
Technology
Patient Stories
About us
Management
Board
Clinical Advisory Board
Careers
Newsroom
Investors
Press releases
What we do
Our approach
Pipeline
Technology
Patient Stories
About us
Management
Board
Clinical Advisory Board
Careers
Newsroom
Investors
Press releases
Overview
Press releases
Events
Corporate Governance
Shareholder & stock info
Financial reports
Financial calendar
Transactions
Back
Back
Immunicum presents safety and survival data from a clinical phase I/II study with INTUVAX in patients with liver cancer
8:30:00 AM
Keep reading
Immunicum’s CSO Alex Karlsson-Parra awarded the Athena Prize
Read
